Aparito is pleased to announce the appointment of Dr Rashmi Narayana as Chief Scientific Officer (CSO).
Rashmi qualified as a psychiatrist and made her way to healthtech via leadership roles at the American Red Cross, academia, and research management. In health tech, she has held roles as Clinical Director at uMotif, as Head of Clinical Development and Head of Clinical and Regulatory Affairs at Huma and, as Director of Operations at Our Mobile Health.
She has numerous peer-reviewed publications to her name. She holds a Masters in Public Health from the London School of Hygiene and Tropical Medicine and an MBA from Imperial College Business School, London. Over the pandemic, she trained and certified as a leadership coach.
With a wealth of experience in navigating complex healthcare environments and partnering with cross-functional teams in business, academia, start-ups and the NHS, Rashmi joins Aparito at a time of rapid growth and will support the senior team in the key role of CSO.
She will focus her operational knowledge and practical expertise to help Aparito facilitate decentralised and hybrid clinical trials with our biopharma clients.
I’ve known Elin and Chris for years. Elin embodies a mix of expertise, experience, and energy which is essential in healthtech. Her passion and commitment to delivering high quality, patient-centred solutions are infectious. The fact that she’s a female tech founder was an added incentive to join Aparito.
Chris has an uncanny ability to translate the complex tech and regulatory needs of biotech and pharma clients into requirements that make sense for tech teams who build solutions. This is no small feat in the world of decentralised and hybrid clinical trials.I’m excited at the opportunity to support them and the wider team to drive Aparito’s growth while retaining and attracting people who connect with Aparito’s mission.
Dr Rashmi Narayana, Chief Scientific Officer at Aparito
We’re very pleased to have appointed Rashmi to our senior management at this critical time.
Her wealth of experience and insight will be a great asset to drive Aparito’s growth forward!
Dr Elin Haf Davies, CEO of Aparito
